200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 1121-07-9
1121-07-9 | N-Methylsuccinimide
CAS No: 1121-07-9 Catalog No: AG0035EN MDL No:MFCD00005517
Product Description
Catalog Number:
AG0035EN
Chemical Name:
N-Methylsuccinimide
CAS Number:
1121-07-9
Molecular Formula:
C5H7NO2
Molecular Weight:
113.1146
MDL Number:
MFCD00005517
IUPAC Name:
1-methylpyrrolidine-2,5-dione
InChI:
InChI=1S/C5H7NO2/c1-6-4(7)2-3-5(6)8/h2-3H2,1H3
InChI Key:
KYEACNNYFNZCST-UHFFFAOYSA-N
SMILES:
CN1C(=O)CCC1=O
NSC Number:
11324
Properties
Complexity:
125
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
113.048g/mol
Formal Charge:
0
Heavy Atom Count:
8
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
113.116g/mol
Monoisotopic Mass:
113.048g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
37.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.9
Literature
| Title | Journal |
|---|---|
| Embryotoxic potential of N-methyl-pyrrolidone (NMP) and three of its metabolites using the rat whole embryo culture system. | Toxicology and applied pharmacology 20090601 |
| Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer. | Familial cancer 20090101 |
| Comparative developmental toxicities of the three major metabolites of N-methyl-2-pyrrolidone after oral administration in rats. | Journal of applied toxicology : JAT 20070101 |
| K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer. | Journal of surgical oncology 20060615 |
| Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker. | International archives of occupational and environmental health 20030501 |
| Acylating agents as enzyme inhibitors and understanding their reactivity for drug design. | Journal of medicinal chemistry 20020620 |
| N-methylsuccinimide in plasma and urine as a biomarker of exposure to N-methyl-2-pyrrolidone. | International archives of occupational and environmental health 20010501 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.